Familial mesial temporal lobe epilepsy …

Eliane Kobayashi MD PhD

Epilepsy & Seizures

Updated 08.19.2024
Released 07.07.2004
Expires For CME 08.19.2027

Familial mesial temporal lobe epilepsy

Author: Eliane Kobayashi MD PhD

See Contributor Disclosures

Editor: Jerome Engel Jr MD PhD

Familial mesial temporal lobe epilepsy

In This Article

Quick Link

Introduction

Overview

In this article, the author reports on novel findings related to polygenic risk scores in patients with familial mesial temporal lobe epilepsy.

Key points

	• Familial mesial temporal lobe epilepsy cannot be distinguished from nonfamilial cases on the basis of clinical, EEG, or MRI findings.
	• Some families have a benign outcome, whereas others have a more heterogeneous presentation, including refractory patients.
	• Hippocampal atrophy is a common feature in some families, not always associated with poor seizure control.
	• No specific genes have been established for this syndrome thus far, although linkage to different loci and mutation in the DEPDC5 gene were described in individual families.
	• Prevalence of familial mesial temporal lobe epilepsy is estimated at 20% to 24% of families with nonacquired focal epilepsy.

Historical note and terminology

Genetic factors in the causation of epilepsy have been recognized since the time of Hippocrates. However, until the second half of the 20th century, generalized epilepsies were thought to be genetic in origin, whereas focal epilepsies were largely attributed to environmental factors, such as birth injuries, infections, postnatal head trauma, and brain lesions such as tumors and vascular insults.

In a series of publications (08; 04; 05; 06) based on family studies of patients operated for focal epilepsy at the Montreal Neurological Hospital, Eva Andermann was able to demonstrate that genetic factors were important in patients with focal epilepsy, particularly temporal lobe epilepsy, and that both generalized and focal epilepsies fit a model of multifactorial inheritance (now termed complex inheritance), with interaction of one or more genes and environmental factors.

It was only in the 1990s that several autosomal dominant forms of focal epilepsy were described by the group of Berkovic and Steinlein (19). These included: autosomal dominant nocturnal frontal lobe epilepsy, familial temporal lobe epilepsy, familial focal epilepsy with variable foci, and autosomal dominant rolandic epilepsy with speech dyspraxia.

The first description of familial occurrence of temporal lobe epilepsy was in 1994 by Berkovic and colleagues who described familial temporal lobe epilepsy as a benign syndrome with late seizure onset, no history of prolonged febrile seizures, and no MRI evidence for mesial temporal sclerosis (15). However, subsequent familial temporal lobe epilepsy series identified patients who were not as benign, with a high proportion of hippocampal atrophy, some of whom required surgical treatment for their epilepsy (24; 60). These families showed intrafamilial and interfamilial phenotypic heterogeneity with respect to history of prolonged febrile seizures, severity of the epilepsy and presence of hippocampal atrophy. The original series of Berkovic and colleagues (15; 17) was population-based, arising from a twin study, whereas the later publications were hospital-based.

Familial temporal lobe epilepsy was included in the proposal for classification of epileptic syndromes by the International League Against Epilepsy (ILAE), supporting it as a well-defined syndrome (35; 34). It has been further maintained in the 2010 ILAE commission report as an adolescence-adulthood electroclinical syndrome (14).

With the description of the lateral form of familial temporal lobe epilepsy, also known as autosomal dominant epilepsy with auditory features (73) and associated with mutations in the LGI-1 gene on chromosome 10q (51; 71), the distinction between mesial and lateral families became more obvious (19; 60; 61; 55; 78; 93; 16; 09).

It is important to recognize that it is impossible to distinguish between patients with familial and nonfamilial temporal lobe epilepsy based solely on the clinical presentation, for both mesial and lateral forms. As the family history is not always accurately documented, and because some family members are asymptomatic or very mildly affected, many so-called “sporadic” or “isolated” patients may actually have a familial epilepsy syndrome.

Clinical manifestations

Presentation and course

Familial mesial temporal lobe epilepsy is characterized by seizures with mesial temporal semiology (rising epigastric sensation, psychic and experiential phenomena). Déjà-vu and jamais-vu appear to be over-represented in this group of patients (07). Focal impaired awareness seizures with oral or manual automatisms and prominent postictal confusion (identical to those observed in nonfamilial mesial temporal lobe epilepsy) are frequent. Focal to bilateral tonic-clonic seizures can occur, usually at the beginning of the disease, before treatment is initiated. Age at seizure onset may vary from 1 to 56 years, with a mean of 10 years (57). History of febrile seizures in infancy seems to be less frequent (around 11%) (57) than in a surgical familial mesial temporal lobe epilepsy series alone (30%) (58), and much less frequent than in a random surgical temporal lobe epilepsy series not selected for familial temporal lobe epilepsy (40%) (01). Familial mesial temporal lobe epilepsy is inherited as an autosomal dominant trait with incomplete penetrance, although complex inheritance cannot be ruled out in some families.

Interictal EEG abnormalities consist of unilateral or bilateral epileptiform discharges over mesiotemporal regions, best observed with zygomatic or sphenoidal electrodes. Ictal recordings show rhythmic activity over the anterior and mesial temporal regions. Although the majority of patients have a benign clinical course, including spontaneous remission, refractory seizures may occur in up to 29% of patients (57). MRI shows varying degrees of hippocampal atrophy and of hyperintense T2 signal (57), and this may also be found in asymptomatic family members (59). However, hippocampal atrophy is more frequent and more severe in patients with refractory seizures (60; 57).

In a series by Crompton and colleagues, 20 families with familial mesial temporal lobe epilepsy have been described (30). Affected family members had a benign outcome except for one individual who required surgery (normal MRI and normal pathology). Contrary to the first description from this group, which was population-based, this new series was also composed of patients who had been referred to the investigators. It should be noted that few families in this series were identified through probands that did not have temporal lobe epilepsy.

Another clinical, MRI, and EEG study evaluated outcome predictors in 17 families from a Brazilian series over a mean of 7.6 years of follow-up (72). The authors found that patients with infrequent seizures could develop frequent seizures (17.6%) or seizure freedom (23.5%). Twenty-one percent of patients who were seizure-free had recurrence, but with infrequent seizures. Refractory patients remained uncontrolled unless they had undergone surgery, and 12% of asymptomatics presented with infrequent seizures. Predictive factors of poor outcome were hippocampal atrophy on MRI and interictal epileptiform discharges on EEG.

Prognosis and complications

Although the first description of familial mesial temporal lobe epilepsy defined it as a benign condition (15; 17), it is now well-known that some patients may be refractory to medical treatment. Overall, 81% of patients with familial mesial temporal lobe epilepsy achieved good seizure control on medication or remitted spontaneously. Refractory seizures were observed in 19%, and surgical treatment was considered in these cases (58). When unilateral or clearly asymmetric bilateral EEG-MRI abnormalities were observed, patients with familial mesial temporal lobe epilepsy had an overall likelihood of 85% to become seizure-free following surgery (58). Indeed, a positive family history of epilepsy and of febrile seizures has been associated with long-term remission following surgery in large cohorts of patients with mesial temporal lobe epilepsy (01; 33).

Memory deficits have been observed in familial mesial temporal lobe epilepsy patients, and frequent seizures potentiate the effect of hippocampal atrophy on memory performance (02). As observed in classical mesial temporal lobe epilepsy series, left hippocampal atrophy correlates with verbal memory and general memory deficit, whereas no correlation between right hippocampal atrophy and visual memory deficit was observed.

Clinical vignette

Hippocampal atrophy with hyperintense T2 signal and abnormal hippocampal internal structure was identified in these three siblings with familial mesial temporal lobe epilepsy.

Familial mesial temporal lobe epilepsy (MRI)

Coronal T1-IR and T2-weighted images of three siblings (III-4 and III-5 are dizygotic twins) with familial mesial temporal lobe epilepsy, from the family represented in the pedigree. Hippocampal atrophy with hyperintense T2 sig...

Patient III-3 was a 50-year-old man who had focal impaired awareness seizures with rare focal to bilateral tonic-clonic seizures since the age of 4 and had not received medication for several years. He had sporadic focal seizures only when he drank alcohol. His MRI showed left hippocampal atrophy. Patient III-4 was a 47-year-old woman who had a simple febrile seizure when she was 2 years old. She started having focal impaired awareness seizures with occasional focal to bilateral tonic-clonic seizures at age 9 years. She experienced frequent seizures, refractory to medication, and her MRI showed bilateral hippocampal atrophy. Patient III-5 was a 47-year-old woman, the twin sister of patient III-3, who had only had a few seizures in her life. The first seizure with focal to bilateral tonic-clonic presentation was at 8 years. She never took anti-epileptic medications, and her sporadic seizures were associated with major stress or alcohol intake. Her MRI showed bilateral hippocampal atrophy with left side predominance.

Biological basis

Etiology and pathogenesis

The etiology of familial epilepsies must first be determined by the genetic basis that indicates an inherited disease and secondly by the structural and functional abnormalities that are associated with this genetic background.

No single gene molecular basis has been confirmed for familial mesial temporal lobe epilepsy to date, although several loci have been mapped. In a French family with febrile seizures and nonlesional temporal lobe epilepsy occurring in the same family members, there was linkage to chr 18qter as well as to chr 1q25-q31, although the latter did not reach a lod score of 3.0 (13). These authors suggested that this might represent digenic inheritance. Linkage to chr 12q22-q23.3 has been described in a Belgian kindred with familial mesial temporal lobe epilepsy and febrile seizures (26). A de novo 12q22-q23.3 duplication has been identified through array-CGH performed in a patient with dysmorphic features and temporal lobe epilepsy (94).

Linkage to chr 18p11.3-11.2 has been demonstrated in one large Brazilian kindred originally described by Kobayashi and colleagues (60; 68). The linkage to chromosome 18p11.31 in one Brazilian family has shown a Z(max) of 3.12 at D18S452 using the presence of hippocampal atrophy or hyperintense hippocampal T2 signal in MRI for phenotypic classification, suggesting that the structural abnormality itself segregates independently from the clinical manifestations (70). Linkage to chr 4q13.2-q21.3 was demonstrated in a large American family with four generations of affected individuals and no MRI abnormalities (47). However, confirmation of these loci in other families has not yet been reported (85), again suggesting the possibility of complex inheritance. A locus on chr 3q has been identified in two families with nonlesional mesial temporal lobe epilepsy (25; 39).

Various polymorphisms have been found in association with mesial temporal lobe epilepsy, but these could not be replicated in larger cohorts of patients (89; 22). An increased frequency of the T allele at the 511 position of the interleukin 1beta gene has been described among patients with mesial temporal lobe epilepsy with hippocampal sclerosis as compared with patients without hippocampal sclerosis and with controls; it was even higher in those with a history of prolonged febrile seizures (52; 53). However, this has not been confirmed in other series (20; 50; 74). Overrepresentation of a functional polymorphism in the prodynorphin gene promoter (possibly related to seizure suppression) has been found in patients with temporal lobe epilepsy and a positive family history of epilepsy as compared to controls (84).

A GABA B receptor 1 polymorphism (G1465A) in patients with mesial temporal lobe epilepsy was overrepresented as compared to the normal population, especially in those with refractory seizures (43; 42). However, other studies failed to replicate such findings (89; 22). Mutations and polymorphisms in other GABA receptor genes (GABRA1, GABRA5, GABRG2, and GABRD) were also excluded in patients with temporal lobe epilepsy and previous history of febrile seizures (63). Polymorphisms of the serotonin transporter gene (5-HTT) have been reported in association with temporal lobe epilepsy (64). The presence of all these polymorphisms would suggest a polygenic or multifactorial mode of inheritance, as first hypothesized by Andermann (04; 05; 06).

Mutations in the SCN1A and SCN1B genes, encoding the sodium channel alpha 1 and beta 1 subunits, respectively, have been identified in affected individuals with the mesial temporal lobe epilepsy phenotype in families with genetic epilepsy with febrile seizures plus (GEFS+) (27). However, these mutations have not yet been reported in pure familial mesial temporal lobe epilepsy kindreds. In addition, no linkage to the SCN2A gene (69) or to voltage-gated potassium channels (67) has been found in Brazilian familial mesial temporal lobe epilepsy kindreds.

No families with familial mesial temporal lobe epilepsy were found to have an LGI-1 mutation, not even those families in which one or more members had auditory features alone or in association with mesial symptoms (78; 11; 16; 85). This further supports the fact that familial mesial temporal lobe epilepsy and familial lateral temporal lobe epilepsy constitute distinct genetic syndromes. Loss-of-function mutations in the DEPDC5 gene on chromosome 22q, encoding the DEP domain containing 5 protein and associated with familial focal epilepsy with variable foci, have been identified in two kindreds with familial mesial temporal lobe epilepsy (48).

A study evaluated the contribution of common risk variants for focal epilepsy in a multicenter cohort of familial mesial temporal lobe epilepsy using polygenic risk scores (46). Polygenic risk scores consist of a weighted sum of the number of common epilepsy risk alleles an individual carries. A total of 134 Australian and Italian families known for familial mesial temporal lobe epilepsy were studied and compared to controls, including 227 affected individuals, 124 unaffected relatives, and 16,077 population controls. Affected individuals had significantly higher polygenic risk scores for focal epilepsy compared to controls. Interestingly, unaffected family members also showed elevated scores, but these did not reach statistical significance.

Detailed phenotyping is crucial to allow gene discovery, which has not yet been advanced in familial mesial temporal lobe epilepsy as compared to other focal familial epilepsy syndromes. Familial aggregation of focal seizure types and semiology has been systematically assessed in the Epilepsy Phenome/Genome Project cohort comprising 302 individuals with nonacquired focal epilepsy from 149 families (90). As expected, fear/anxiety and déjà vu/jamais vu showed significant familial aggregation in temporal lobe epilepsy families, representing 24% of kindreds.

The presence of clear-cut hippocampal atrophy in both affected and asymptomatic family members in familial mesial temporal lobe epilepsy suggests that the hippocampal abnormalities themselves could be inherited, and not necessarily lead to epilepsy (59). The phenotype would then be dependent on interaction with other modifying factors. Three published papers addressed the possibility of inherited hippocampal abnormality. Fernandez and colleagues studied families of patients with a previous history of febrile seizures, including asymptomatic individuals (40). They observed subtle abnormalities in hippocampal configuration, internal structure and volume in subjects with and without febrile seizures. This suggested the presence of preexisting hippocampal malformations as an associated factor leading to febrile seizures and subsequent hippocampal sclerosis. A subsequent study of children with prolonged febrile seizures and their monozygotic asymptomatic twins did not confirm these findings (49). Another study, including volumetry and T2 relaxometry, did not confirm the presence of hippocampal atrophy, although the volumes from asymptomatic family members was lower than controls, suggesting that this finding could be a predisposing abnormality (92).

Volumetric studies of the temporal lobes showed similar patterns of atrophy in patients with familial and nonfamilial mesial temporal lobe epilepsy (41). Yasuda and colleagues described differences in the extent of gray matter atrophy determined by MRI voxel-based morphometry in patients with mesial temporal lobe epilepsy with and without family history (100). Familial patients showed a less widespread pattern of atrophy and had less severe dysfunction in neuropsychological assessment and less frequent history of precipitating injury as compared to those without family history of seizures. Overall, these findings support again the influence of genetic factors determining hippocampal abnormalities in familial mesial temporal lobe epilepsy whereas more widespread atrophy in nonfamilial cases might be related to environmental factors.

A longitudinal quantitative MRI study was performed in patients with familial mesial temporal lobe epilepsy and compared to sporadic cases, showing that patients with familial mesial temporal lobe epilepsy have progressive hippocampal atrophy that occurs independently of seizure frequency (29). In a longitudinal study involving 21 patients with familial mesial temporal lobe epilepsy and nine asymptomatic relatives, the same group reported hippocampal T2 relaxometry changes in the mean time interval between MRIs of 4.4 ± 1.5 years (87). Interestingly, MRI-negative patients and asymptomatic relatives showed intermediate relaxometry values as compared to MRI-positive patients and controls. This further suggests genetically determined, and in some individuals, seizure-independent hippocampal abnormalities.

Mexican kindreds described as familial mesial temporal lobe epilepsy in a large cohort showed MRI abnormalities in 25% of affected individuals, including 15% with MRI signs of hippocampal sclerosis and 10% described as hippocampal “hypotrophy” (criteria for the latter, however, neither explained nor illustrated). As the authors described some affected family members with unusual seizure semiology features within mesial temporal lobe epilepsies, some classified as having extra temporal epilepsy foci (including parietal and frontal epilepsy), the differential diagnosis of familial focal epilepsy with variable foci should be considered (44).

Subtle reduced cortical volumes in the anteromedial temporal cortex of asymptomatic siblings of patients with sporadic mesial temporal lobe epilepsy associated with hippocampal sclerosis suggest that such localized traits are possibly heritable (03). Interestingly, the alterations of cortical morphology found in unaffected siblings of patients with left mesial temporal lobe epilepsy associated with underlying hippocampal sclerosis (left entorhinal cortex and parahippocampal gyrus) differed from unaffected siblings of right-sided patients (right entorhinal cortex and temporal pole). In 127 asymptomatic first-degree relatives of patients with mesial temporal lobe epilepsy associated with hippocampal sclerosis from three independent cohorts, no changes in cortical thickness have been confirmed, which suggests that changes in the cortical surface area may represent an inherited trait that preceded onset of seizures (03; 23).

Available qualitative pathology from surgical specimens obtained from operated familial mesial temporal lobe epilepsy patients showed the typical pattern of mesial temporal sclerosis: selective neuronal loss in CA1, CA3 and CA4 with relative preservation of CA2, and variable involvement of the amygdala and parahippocampal region (58). A more detailed study on the pathological substrate of familial mesial temporal lobe epilepsy has been presented by Andrade-Valenca and colleagues (10). They evaluated the surgical specimens from 20 familial mesial temporal lobe epilepsy and 39 sporadic mesial temporal lobe epilepsy patients. No differences could be found in cell densities in CA subfields, fascia dentata, polymorphic region, subiculum, prosubiculum, and presubiculum. However, greater intensity of mossy fibers in the fascia dentata-inner molecular layer was found in patients with sporadic mesial temporal lobe epilepsy. The authors raised the hypothesis that patients with familial mesial temporal lobe epilepsy respond differently to plastic changes induced by cell loss, neuronal deafferentation, or epileptic seizures.

mRNA expression profiles in hippocampal surgical brain specimens of patients with familial mesial temporal lobe epilepsy show a different profile compared to sporadic mesial temporal lobe epilepsy (66). In familial specimens, there is an over-representation of the biological pathways related to protein response, mRNA processing, and synaptic plasticity and function. In sporadic specimens, the gene expression profile suggests that the inflammatory response is highly activated. Although an enrichment of gene sets involved in inflammatory cytokines and mediators and chemokine receptor pathways was identified in both groups, there was also an enrichment of epidermal growth factor signaling, prostaglandin synthesis and regulation, and microglia pathogen phagocytosis pathways in sporadic mesial temporal lobe epilepsy. These molecular signatures suggest different underlying molecular mechanisms that may have implications for the development of therapeutic approaches.

The observation of mesial temporal sclerosis in operated familial mesial temporal lobe epilepsy patients who became seizure-free suggests that mesial temporal sclerosis represents the epileptogenic substrate, at least in some of these families, analogous to what is observed in nonfamilial or “sporadic” mesial temporal lobe epilepsy cases.

Most likely, familial mesial temporal lobe epilepsy will be found to have a major gene leading to hippocampal abnormalities, and the phenotype could be influenced by additional genetic and environmental modifying factors.

The identification of a positive family history of seizures in patients with mesial temporal lobe epilepsy is not sufficient for a diagnosis of familial mesial temporal lobe epilepsy. The best definition of familial mesial temporal lobe epilepsy is based on the familial recurrence of mesial temporal lobe epilepsy, which is defined by clinical-EEG criteria according to the ILAE recommendations (28), in the absence of any suggestion of other focal or generalized epilepsy syndromes in other affected family members. Thus, the observation of at least two patients with mesial temporal lobe epilepsy in one family is necessary but not sufficient for the definition of familial mesial temporal lobe epilepsy. The observation of an autosomal dominant inheritance pattern with incomplete penetrance implies the presence of asymptomatic carriers of the genetic abnormalities, who can transmit the disease to their offspring. Therefore, we should consider inclusion of families not only with affected first-degree relatives, but also with affected second- and third-degree relatives. This criterion has not been employed in some reported series, leading to exclusion of many possible familial mesial temporal lobe epilepsy kindreds (76).

The presence of family members with episodes of either generalized tonic-clonic seizures only with no witnessed onset, or with febrile seizures alone, does not exclude the diagnosis of familial mesial temporal lobe epilepsy because these do not fulfill criteria for other epilepsy syndromes. Families with individuals who have such clinical manifestations should also be considered to have familial mesial temporal lobe epilepsy, as long as at least two affected individuals fulfill the clinical and EEG criteria for mesial temporal lobe epilepsy and no other epilepsy type is found to suggest familial focal epilepsy with variable foci.

Epidemiology

There is no predominance of familial mesial temporal lobe epilepsy in any particular ethnic group to our knowledge. Families with familial mesial temporal lobe epilepsy have been described in Australia, Canada, Brazil, Italy, Belgium, France, Macedonia, and Mexico. The real prevalence of familial mesial temporal lobe epilepsy worldwide is probably underestimated.

Ascertainment of these families requires detailed questioning of patients and family members. This has only been emphasized because, in the past, mesial temporal lobe epilepsy as well as other focal epilepsies were considered to be symptomatic and due largely to environmental factors. A preliminary hospital-based study found that familial mesial temporal lobe epilepsy represented 7% of all patients with mesial temporal lobe epilepsy (60).

Among 62 families with focal epilepsy evaluated through the Epi4K Consortium, 37% (n = 23) had familial temporal lobe epilepsy, most of them with seizure semiology indicating mesial temporal focus. Two families had reported symptoms in keeping with FLTLE and three families had family members with semiologies indicative of both mesial and lateral foci. MRI, whenever available, did not show evidence of hippocampal atrophy in visual analysis (36).

An interesting report on the incidence of familial mesial temporal lobe epilepsy in patients with newly diagnosed MRI negative mesial temporal lobe epilepsy used a structured interview of first-degree relatives of patients seen in a First Seizure Clinic, and compared data obtained with pairwise age- and sex-matched controls (75). Whereas at clinic assessment only 2 of 40 patients had been recognized to have familial mesial temporal lobe epilepsy, blind review of interview transcripts in their relatives allowed diagnosis of mesial temporal lobe epilepsy in 9 of 121 relatives, with intense déjà vu being the most common feature. Physiological déjà vu was commonly and equally prevalent in relatives and controls. The differentiation of epileptic and nonepileptic déjà vu features in this study thus resulted in the diagnosis of eight familial mesial temporal lobe epilepsy kindreds (18.2%) in whole cohort.

In Macedonia, four small kindreds with possible familial mesial temporal lobe epilepsy were identified from active inquiry on family history of seizures among 52 patients with mesial temporal lobe epilepsy seen in a 2-year period (31).

Differential diagnosis

Confusing conditions

A family history of seizures is common among mesial temporal lobe epilepsy patients. Many of them have one or more relatives who have experienced a single episode compatible with either focal impaired awareness seizures or generalized tonic-clonic seizures, and a history of febrile seizures is also frequently found. However, unless there are two individuals in the family with well-defined mesial temporal lobe epilepsy, a diagnosis of familial mesial temporal lobe epilepsy cannot be made.

In addition, there are other familial epilepsy syndromes in which patients with mesial temporal lobe epilepsy are found. In familial focal epilepsy with variable foci (81; 99; 98; 21; 18), most reported families mapped to chromosome 22q. Mutations in the DEPDC5 gene have been identified in familial focal epilepsy with variable foci families, but also in other familial focal epilepsies (32; 48; 65). Affected family members may present with various forms of focal epilepsy, including frontal lobe epilepsy and mesial temporal lobe epilepsy (56).

A DEPDC5 nonsense mutation (c.918C> G; p.Tyr306*) has been identified in a familial mesial temporal lobe epilepsy family with two affected members, expanding on the possible phenotypes associated with this gene originally linked to familial focal epilepsy with variable foci (86; 12). In addition, two siblings with refractory mesial temporal lobe epilepsy had a pathological diagnosis of focal cortical dysplasia IIIa (ie, hippocampal sclerosis and focal cortical dysplasia) in brain tissue from anterior temporal resection, but no genetic diagnosis was made (38). Possibly pathogenic variants in the DEPDC5 gene, associated with FFEVF, were found in sporadic temporal lobe epilepsy patients with and without hippocampal atrophy (91).

Ricos and colleagues investigated mutations in NPRL2 and NPRL3 genes, which together with DEPDC5, are part of the GATOR1 complex regulating mTOR pathway, and they found mutations in each of these genes in small kindreds composed of only two patients with temporal lobe epilepsy that could have a mesial phenotype, but that was not clearly specified (77).

In GEFS+ related to mutations in genes SCN1A, SCN2A, SCN1B, and GABRG2 (97; 95; 96; 37; 62; 88; 45), patients may present heterogeneous epilepsy phenotypes. Febrile seizures are the most common phenotype, followed by febrile seizures plus (FS+), where individuals have seizures with fever that may persist beyond the age of 6 years and may be associated with afebrile generalized tonic-clonic seizures (79; 82). Less frequent phenotypes seen in GEFS+ involve other generalized and partial seizure types, including mesial temporal lobe epilepsy (79; 82; 96; 80).

Another focal epilepsy syndrome with some individuals presenting seizure semiology consistent with mesial temporal lobe epilepsy has been described in one large Brazilian kindred and named partial epilepsy with pericentral spikes (54). The majority of affected individuals, however, presented hemitonic or hemiclonic seizures, and molecular analysis showed linkage to chromosome 4p15.

Siren and colleagues described a kindred with heterogeneous benign epilepsy phenotypes (febrile seizures, possible temporal lobe epilepsy, and childhood absences) linked to three loci on chromosomes 5q11.2, 18p11-q11, and 17q12-q24 (83).

It is essential to evaluate the phenotype of all possibly affected individuals before classifying the family to have a specific familial syndrome. In addition, because the severity of the phenotypes in family members may vary, we can never be absolutely sure that an “isolated” or “sporadic” mesial temporal lobe epilepsy patient does not have familial mesial temporal lobe epilepsy. Molecular studies can be helpful in excluding other familial epilepsies with already identified gene mutations.

References

01: Abou-Khalil B, Andermann E, Andermann F, Olivier A, Quesney LF. Temporal lobe epilepsy after prolonged febrile convulsions: excellent outcome after surgical treatment. Epilepsia 1993;34(5):878-83. PMID 8404740
02: Alessio A, Kobayashi E, Damasceno BP, Lopes-Cendes I, Cendes F. Evidence of memory impairment in asymptomatic individuals with hippocampal atrophy. Epilepsy Behav 2004;5(6):981-7. PMID 15582848
03: Alhusaini S, Kowalczyk MA, Yasuda CL, et al. Normal cerebral cortical thickness in first-degree relatives of temporal lobe epilepsy patients. Neurology 2019;92(4):e351-8. PMID 30587513
04: Andermann E. Multifactorial inheritance in the epilepsies. In: Canger R, Angeleri F, Penry JK, editors. Advances in epileptology. XII Epilepsy International Symposium. New York: Raven Press, 1980:297-309.
05: Andermann E. Multifactorial inheritance of generalized and focal epilepsies. In: Anderson VE, editor. Genetic basis of the epilepsies. New York: Raven Press, 1982:355-74.
06: Andermann E. Genetic aspects of the epilepsies. In: Sakai T, Tsuboi T, editors. Genetic aspects of human behavior. Tokyo, 1985:129-45.
07: Andermann E, Abou-Khalil B, Berkovic S, et al. Déjà-vu is the characteristic aura in benign familial temporal lobe epilepsy. Epilepsia 1997;38(Suppl 8):200.
08: Andermann E, Metrakos JD. EEG studies of relatives of probands with focal epilepsy who have been treated surgically. Epilepsia 1969;10(3):415. PMID 4979085
09: Andermann F, Kobayashi E, Andermann E. Genetic focal epilepsies: state of the art and paths to the future. Epilepsia 2005;46(Suppl 10):61-7. PMID 16359475
10: Andrade-Valenca LP, Valença MM, Velasco TR, et al. Mesial temporal lobe epilepsy: clinical and neuropathologic findings of familial and sporadic forms. Epilepsia 2008;49(6):1046-54. PMID 18294201
11: Badhwar A, Racacho L, D’Agostino D, et al. Absence of LGI1 mutations in familial mesial temporal lobe epilepsy with or without auditory features and in sporadic TLE with auditory features. Neurology 2004;62(Suppl 5):A252. PMID 15079010
12: Baulac S. mTOR signaling pathway genes in focal epilepsies. Prog Brain Res 2016;226:61-79.** PMID 27323939
13: Baulac S, Picard F, Herman A, et al. Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25-q31. Ann Neurol 2001;49(6):786-92. PMID 11409431
14: Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51(4):676-85. PMID 20196795
15: Berkovic SF, Howell RA, Hopper JL. Familial temporal lobe epilepsy: a new syndrome with adolescent/adult onset and a benign course. In: Wolf P, editor. Epileptic seizures and syndromes. London: John Libbey & Company Ltd., 1994:257-63.
16: Berkovic SF, Izzillo P, McMahon JM, et al. LGI1 mutations in temporal lobe epilepsies. Neurology 2004a;62(7):1115-9. PMID 15079010
17: Berkovic SF, McIntosh A, Howell RA, Mitchell A, Sheffield LJ, Hopper JL. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 1996;40(2):227-35. PMID 8773604
18: Berkovic SF, Serratosa JM, Phillips HA, et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia 2004b;45(9):1054-60. PMID 15329069
19: Berkovic SF, Steinlein OK. Genetics of partial epilepsies. Adv Neurol 1999;79:375-81. PMID 10514827
20: Buono RJ, Ferraro TN, O'Connor MJ, et al. Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy. Epilepsia 2001;42(6):782-4. PMID 11422336
21: Callenbach PM, van den Maagdenberg AM, Hottenga JJ, et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia 2003;44(10):1298-305. PMID 14510823
22: Cavallieri GL, Lynch JM, Depondt C, et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here. Brain 2005;128(Pt 8):1832-40. PMID 15888540
23: Cendes F. Evidence for a genetic effect in altered cortical surface area but not in cortical thinning in siblings of patients with mesial temporal lobe epilepsy: commentary on: "Abnormal temporal lobe morphology in asymptomatic relatives of patients with hippocampal sclerosis: A replication study." Epilepsia 2019;60(1):e6-7. PMID 30592033
24: Cendes F, Lopes-Cendes I, Andermann E, Andermann F. Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology 1998;50(7):554-7. PMID 9484399
25: Chahine L, Abou-Khalil B, Siren A, et al. A new locus for familial temporal lobe epilepsy on chromosome 3q. Epilepsy Res 2013;106(3):338-44. PMID 24021842
26: Claes L, Audenaert D, Deprez L, et al. Novel locus on chromosome 12q22-q23.3 responsible for familial temporal lobe epilepsy associated with febrile seizures. J Med Genet 2004;41(9):710-4. PMID 15342703
27: Colosimo E, Gambardella A, Mantegazza M, et al. Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation. Epilepsia 2007;48(9):1691-6. PMID 17565594
28: Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4):389-99. PMID 2502382
29: Conz L, Morita ME, Coan AC, et al. Longitudinal MRI volumetric evaluation in patients with familial mesial temporal lobe epilepsy. Front Neurol 2011;14;2:5. PMID 21431086
30: Crompton DE, Scheffer IE, Taylor I, et al. Familial mesial temporal lobe epilepsy: a benign epilepsy syndrome showing complex inheritance. Brain 2010;133(11):3221-31. PMID 20864493
31: Cvetkovska E, Kuzmanovski I, Babunovska M, Boshkovski B, Cangovska TC, Trencevska GK. Phenotypic spectrum in families with mesial temporal lobe epilepsy probands. Seizure 2018;58:13-6. PMID 29605745
32: Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013;45(5):546-51. PMID 23542697
33: Elsharkawy AE, Alabbasi AH, Pannek H, et al. Long-term outcome after temporal lobe epilepsy surgery in 434 consecutive adult patients. J Neurosurg 2009;110(6):1135-46. PMID 19025359
34: Engel J Jr. Report of the ILAE classification core group. Epilepsia 2006;47(9):1558-68. PMID 16981873
35: Engel J Jr; International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796-803. PMID 11422340
36: Epi4K Consortium. Phenotypic analysis of 303 multiplex families with common epilepsies. Brain 2017;140(8):2144-56.** PMID 28899008
37: Escayg A, MacDonald BT, Meisler MH, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000;24(4):343-5. PMID 10742094
38: Fabera P, Krijtova H, Tomasek M, et al. Familial temporal lobe epilepsy due to focal cortical dysplasia type IIIa. Seizure 2015;31:120-3. PMID 26362388
39: Fanciulli M, Di Bonaventura C, Egeo G, et al. Suggestive linkage of familial mesial temporal lobe epilepsy to chromosome 3q26. Epilepsy Res 2014;108(2):232-40. PMID 24315020
40: Fernandez G, Effenberger O, Vinz B, et al. Hippocampal malformation as a cause of familial febrile convulsions and subsequent hippocampal sclerosis. Neurology 1998;50(4):909-17. PMID 9566371
41: Ferreira FT, Kobayashi E, Lopes-Cendes I, Cendes F. Structural abnormalities are similar in familial and nonfamilial mesial temporal lobe epilepsy. Can J Neurol Sci 2004;31(3):368-72. PMID 15376482
42: Gambardella A, Labate A, Giallonardo A, Aguglia U. Familial mesial temporal lobe epilepsies: clinical and genetic features. Epilepsia 2009;50 Suppl 5:55-7. PMID 19469849
43: Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003;60(4):560-3. PMID 12601092
44: Guzmán-Jiménez DE, Campos JB, Venegas-Vega CA, Sánchez MA, Velasco AL. Familial mesial temporal lobe epilepsy in Mexico: inheritance pattern and clinical features. Epilepsy Res 2020;167:106450. PMID 32949980
45: Harkin LA, Bowser DN, Dibbens LM, et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 2002;70(2):530-6. PMID 11748509
46: Harris RV, Oliver KL, Perucca P, et al. Familial mesial temporal lobe epilepsy: clinical spectrum and genetic evidence for a polygenic architecture. Ann Neurol 2023;94(5):825-35. PMID 37597255
47: Hedera P, Blair MA, Andermann E, et al. Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology 2007;68(24):2107-12. PMID 17377072
48: Ishida S, Picard F, Rudolf G, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 2013;45(5):552-5. PMID 23542701
49: Jackson GD, McIntosh AM, Briellmann RS, Berkovic SF. Hippocampal sclerosis studied in identical twins. Neurology 1998;51(1):78-84. PMID 9674783
50: Jin L, Jia Y, Zhang B, et al. Association analysis of a polymorphism of interleukin 1 beta (IL-1 beta) gene with temporal lobe epilepsy in a Chinese population. Epilepsia 2003;44(10):1306-9. PMID 14510824
51: Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal dominant partial epilepsy with auditory features. Nat Genet 2002;30(3):335-41. PMID 11810107
52: Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;47(5):571-4. PMID 10805326
53: Kanemoto K, Kawasaki J, Yuasa S, et al. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003;44(6):796-9. PMID 12790892
54: Kinton L, Johnson MR, Smith SJ, et al. Partial epilepsy with pericentral spikes: a new familial epilepsy syndrome with evidence for linkage to chromosome 4p15. Ann Neurol 2002;51(6):740-9. PMID 12112080
55: Kobayashi E, Andermann F, Andermann E. Familial lateral temporal lobe epilepsy. In: Gilman S, editor. Medlink Neurology. San Diego: MedLink Corporation. Accessed March 2009a.
56: Kobayashi E, Andermann F, Andermann E. Familial partial epilepsy with variable foci. In: Gilman S, editor. Medlink Neurology. San Diego: MedLink Corporation. Accessed March 2009b.
57: Kobayashi E, D’Agostino MD, Lopes-Cendes I, et al. Hippocampal atrophy and T2 weighted signal changes in familial mesial temporal lobe epilepsy. Neurology 2003a;60(3):405-9. PMID 12578919
58: Kobayashi E, D’Agostino MD, Lopes-Cendes I, et al. Outcome of surgical treatment in patients with familial mesial temporal lobe epilepsy. Epilepsia 2003b;44(8):1079-83. PMID 12887440
59: Kobayashi E, Li LM, Lopes-Cendes I, Cendes F. Magnetic resonance imaging evidence of hippocampal sclerosis in asymptomatic, first-degree relatives of patients with familial mesial temporal lobe epilepsy. Arch Neurol 2002a;59(12):1891-4. PMID 12470176
60: Kobayashi E, Lopes-Cendes I, Guerreiro CA, Sousa SC, Guerreiro MM, Cendes F. Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology 2001;56(2):166-172. PMID 11160950
61: Kobayashi E, Santos NF, Torres FR, et al. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch Neurol 2003c;60(11):1546-51. PMID 14623726
62: Lopes-Cendes I, Scheffer IE, Berkovic SF, Rousseau M, Andermann E, Rouleau GA. A new locus for generalized epilepsy with febrile seizures plus maps to chromosome 2. Am J Hum Genet 2000;66(2):698-701. PMID 10677328
63: Ma S, Abou-Khalil B, Blair MA, Sutcliffe JS, Haines JL, Hedera P. Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures. Neurosci Lett 2006;394(1):74-8. PMID 16256272
64: Manna I, Labate A, Gambardella A, et al. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Neurosci Lett 2007;421(1):52-6. PMID 17548158
65: Martin C, Meloche C, Rioux MF, et al. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population. Clin Genet 2014;86(6):570-4. PMID 24283814
66: Maurer-Morelli CV, de Vasconcellos JF, Bruxel EM, et al. Gene expression profile suggests different mechanisms underlying sporadic and familial mesial temporal lobe epilepsy. Exp Biol Med (Maywood) 2022;247(24):2233-50. PMID 36259630
67: Maurer-Morelli CV, Marchesini RB, Secolin R, et al. Linkage study of voltage-gated potassium channels in familial mesial temporal lobe epilepsy. Arq Neuropsiquiatr 2007;65:20-3. PMID 17420821
68: Maurer-Morelli CV, Secolin R, Domingues RR, et al. Genome-wide linkage study identifies a locus for familial mesial temporal lobe epilepsy. Epilepsia 2006a;47(Suppl 4):4231.
69: Maurer-Morelli CV, Secolin R, Marchesini RB, et al. The SCN2A gene is not a likely candidate for familial mesial temporal lobe epilepsy. Epilepsy Res 2006b;71:233-6. PMID 16914293
70: Maurer-Morelli CV, Secolin R, Morita ME, et al. A locus identified on chromosome18P11.31 is associated with hippocampal abnormalities in a family with mesial temporal lobe epilepsy. Front Neurol 2012;3:124. PMID 23015801
71: Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S, et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal lobe epilepsy. Hum Mol Genet 2002;11(9):1119-28. PMID 11978770
72: Morita ME, Yasuda CL, Betting LE, et al. MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy. Neurology 2012;79(24):2349-54. PMID 23197748
73: Ottman R, Risch N, Hauser WA, et al. Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 1995;10(1):56-60. PMID 7647791
74: Ozkara C, Uzan M, Tanriverdi T, et al. Lack of association between IL-1beta/alpha gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis. Seizure 2006;15(5):288-91. PMID 16546408
75: Perucca P, Crompton DE, Bellows ST, et al. Familial mesial temporal lobe epilepsy and the borderland of déjà vu. Ann Neurol 2017;82(2):166-76.** PMID 28681459
76: Picard F, Baulac S, Kahane P, et al. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain 2000;123(Pt 6):1247-62. PMID 10825362
77: Ricos MG, Hodgson BL, Pippucci T, et al. Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol 2016;79(1):120-31.** PMID 26505888
78: Santos NF, Sousa SC, Kobayashi E, et al. Clinical and genetic heterogeneity in familial temporal lobe epilepsy. Epilepsia 2002;43 Suppl 5:136. PMID 12121308
79: Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997;120(Pt 3):479-90. PMID 9126059
80: Scheffer IE, Harkin LA, Grinton BE, et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007;130(Pt 1):100-9. PMID 17020904
81: Scheffer IE, Phillips HA, O'Brien CE, et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol 1998;44(6):890-9. PMID 9851433
82: Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol 1999;45(1):75-81. PMID 9894880
83: Siren A, Polvi A, Chahine L, et al. Suggestive evidence for a new locus for epilepsy with heterogeneous phenotypes on chromosome 17q. Epilepsy Res 2010;88(1):65-75. PMID 19914042
84: Stogmann E, Zimprich A, Baumgartner C, Aull-Watschinger S, Hollt V, Zimprich F. A functional polymorphism in the prodynorphin gene promoter is associated with temporal lobe epilepsy. Ann Neurol 2002;51(2):260-3. PMID 11835385
85: Striano P, Gambardella A, Coppola A, et al. Familial mesial temporal lobe epilepsy (FMTLE): a clinical and genetic study of 15 Italian families. J Neurol 2008;255(1):16-23. PMID 18004642
86: Striano P, Serioli E, Santulli L, et al. DEPDC5 mutations are not a frequent cause of familial temporal lobe epilepsy. Epilepsia 2015;56(10):e168-71.** PMID 26216793
87: Suemitsu LA, Yasuda CL, Morita ME, et al. Longitudinal analysis of hippocampal T2 relaxometry in FMTLE. Epilepsy Behav 2014;36:154-8. PMID 24926943
88: Sugawara T, Tsurubuchi Y, Agarwala KL, et al. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A 2001;98(11):6384-9. PMID 11371648
89: Tan NC, Mulley JC, Berkovic SF. Genetic association studies in epilepsy: "the truth is out there". Epilepsia 2004;45(11):1429-42. PMID 15509244
90: Tobochnik S, Fahlstrom R, Shain C, Winawer MR, EPGP Investigators. Familial aggregation of focal seizure semiology in the Epilepsy Phenome/Genome Project. Neurology 2017;89(1):22-8.** PMID 28566546
91: Tsai MH, Chan CK, Chang YC, et al. DEPDC5 mutations in familial and sporadic focal epilepsy. Clin Genet 2017;92(4):397-404. PMID 28170089
92: Tsai MH, Pardoe HR, Perchyonok Y, et al. Etiology of hippocampal sclerosis: evidence for a predisposing familial morphologic anomaly. Neurology 2013;81(2):144-9. PMID 23749796
93: Vadlamudi L, Scheffer IE, Berkovic SF. Genetics of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003;74(10):1359-61. PMID 14570824
94: Vari MS, Traverso M, Bellini T, et al. De novo 12q22.q23.3 duplication associated with temporal lobe epilepsy. Seizure 2017;50:80-2. PMID 28633043
95: Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001;68(4):859-65. PMID 11254444
96: Wallace RH, Scheffer IE, Parasivam G, et al. Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology 2002;58(9):1426-9. PMID 12011299
97: Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 1998;19(4):366-70. PMID 9697698
98: Xiong L. Identification, clinical characterization, and molecular genetic studies of familial partial epilepsy with variable foci. PhD thesis, McGill University, 2002.
99: Xiong L, Labuda M, Li DS, et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet 1999;65(6):1698-710. PMID 10577924
100: Yasuda CL, Morita ME, Alessio A, et al. Relationship between environmental factors and gray matter atrophy in refractory MTLE. Neurology 2010;74(13):1062-8. PMID 20350980

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Eliane Kobayashi MD PhD

Dr. Kobayashi of McGill University received honorariums for advisory board membership from Palladin Laboratories and Jazz Pharmaceuticals.
See Profile

Editor

Jerome Engel Jr MD PhD

Dr. Engel of the David Geffen School of Medicine at the University of California, Los Angeles, has no relevant financial relationships to disclose.
See Profile

Former Authors

Eva Andermann MD PhD
Frederick Andermann MD

Patient Profile

Age range of presentation: 1 month to 64 years
Sex preponderance: male=female
Heredity: heredity typical
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Localization-related epilepsy: G40
ICD-11: Other specified genetic epileptic syndromes with variable age of onset: 8A61.4Y
OMIM: Familial temporal lobe epilepsy: %608096

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Familial mesial temporal lobe epilepsy

Differential Diagnosis

other familial epilepsy syndromes
familial focal epilepsy with variable foci
familial lateral temporal lobe epilepsy
genetic epilepsy with febrile seizure plus
mesial temporal lobe epilepsy
- nonfamilial mesial temporal lobe epilepsy

Also Relevant

Epilepsy
Familial focal epilepsy with variable foci
Febrile seizures
Mesial temporal lobe epilepsy with hippocampal sclerosis
Neocortical temporal lobe seizures

Clinical Categories

Epilepsy & Seizures

Patient Handouts

Seizure first aid

Web References

Guidelines

Familial mesial temporal lobe epilepsy …

Familial mesial temporal lobe epilepsy

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Anti-LGI1 encephalitis

Self-limited (familial) neonatal epilepsy

Alcohol withdrawal seizures

Epileptic lesions due to malformation of cortical development

Epileptic spasms

Sleep and epilepsy

Neocortical temporal lobe seizures

Jacksonian seizures

Familial mesial temporal lobe epilepsy

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Anti-LGI1 encephalitis

Self-limited (familial) neonatal epilepsy

Alcohol withdrawal seizures

Epileptic lesions due to malformation of cortical development

Epileptic spasms

Sleep and epilepsy

Neocortical temporal lobe seizures

Jacksonian seizures

This is an article preview.
Start a Free Account
to access the full version.